Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lobular Carcinoma In Situ”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01112254
What this trial is testing

Evaluation of the Diagnostic Performance of MRI±Biopsy to Optimize Resection of Ductal Carcinoma In Situ (DCIS) Breast Cancer

Who this might be right for
Breast Cancer
Gustave Roussy, Cancer Campus, Grand Paris 360
Not applicableLooking for participantsNCT03448926
What this trial is testing

The PREDICT Registry:

Who this might be right for
DCISStage 0 Breast CancerDuctal Breast Carcinoma In Situ
PreludeDx 3,000
Not applicableStudy completedNCT00388115
What this trial is testing

Radiofrequency Ablation in Treating Patients With Early Invasive Breast Cancer or Ductal Carcinoma in Situ

Who this might be right for
Breast Cancer
University of California, Davis 15
Testing effectiveness (Phase 2)Study completedNCT03931928
What this trial is testing

Genotype and Phenotype Guided Supplementation of TAMoxifen Standard Therapy With ENDOXifen in Breast Cancer Patients

Who this might be right for
Breast CancerDCIS
Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF) 356
Testing effectiveness (Phase 2)Study completedNCT02636582
What this trial is testing

Nelipepimut-S Plus GM-CSF Vaccine Therapy in Treating Patients With Breast Cancer

Who this might be right for
Breast Ductal Carcinoma In Situ
National Cancer Institute (NCI) 43
Not applicableWithdrawnNCT03868475
What this trial is testing

Comparing Vacuum-Assisted Percutaneous Excision to Open Surgical Excision for Borderline or High-Risk Breast Lesions

Who this might be right for
Breast FibroadenomaAtypical Ductal HyperplasiaAtypical Lobular Hyperplasia+7 more
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Not applicableNot Yet RecruitingNCT07245316
What this trial is testing

Avoiding Surgery in Estrogen Receptor Positive Atypical Ductal Hyperplasia and In-situ Carcinoma Treated With Endocrine Treatment Trial

Who this might be right for
Ductal Carcinoma in Situ of the Breast
Jeong Eon Lee 340
Not applicableStudy completedNCT06388304
What this trial is testing

THRIVE Study: Positive Affect Training for Endocrine Therapy Medication Adherence

Who this might be right for
Breast CancerDCIS
Joanna Arch 39
Not applicableStudy completedNCT01293032
What this trial is testing

Hormone Therapy Or Chemotherapy Before Surgery Based on Gene Expression Analysis in Treating Patients With Breast Cancer

Who this might be right for
Ductal Breast Carcinoma in SituLobular Breast Carcinoma in SituStage II Breast Cancer+4 more
Virginia Commonwealth University 59
Testing effectiveness (Phase 2)Study completedNCT00354640
What this trial is testing

Simvastatin and Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ or Invasive Breast Cancer

Who this might be right for
Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 11
Not applicableStudy completedNCT02121873
What this trial is testing

The Breast Duct: Pilot Study of Genomic Sequencing of Exfoliated Ductal Cells Obtained Through Endoscopy and Lavage

Who this might be right for
Breast CancerPreneoplastic ConditionsDuctal Carcinoma in Situ
Atossa Therapeutics, Inc. 6
Early research (Phase 1)Study completedNCT00245024
What this trial is testing

Sulindac in Preventing Breast Cancer in Women at High Risk for Breast Cancer

Who this might be right for
Breast Cancer
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Study completedNCT00244959
What this trial is testing

Anastrozole in Treating Postmenopausal Women With DCIS or Stage I-III Breast Cancer

Who this might be right for
Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 54
Not applicableStudy completedNCT00569543
What this trial is testing

Effect of Tamoxifen or an Aromatase Inhibitor on Estrogen Metabolism in Women Treated for Newly Diagnosed Breast Cancer

Who this might be right for
Breast Cancer
University of Nebraska 27
Not applicableActive Not RecruitingNCT04537312
What this trial is testing

Prospective Pilot Study of Robot-assisted Nipple Sparing Mastectomy (RNSM)

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+13 more
Ohio State University Comprehensive Cancer Center 4
Not applicableNot Yet RecruitingNCT07527468
What this trial is testing

HISMAR: Intraoperative Margin Assessment Using the Histolog® Scanner to Reduce Reoperation in Breast-Conserving Surgery

Who this might be right for
Breast CancerDuctal Carcinoma In SituInvasive Lobular Carcinoma+1 more
Hôpital du Valais 228
Not applicableLooking for participantsNCT04494945
What this trial is testing

Identifying and Caring for Individuals With Inherited Cancer Syndrome

Who this might be right for
BRCA1/2-Associated Hereditary Breast and Ovarian Cancer SyndromeBreast Ductal Carcinoma In SituHematopoietic and Lymphoid System Neoplasm+3 more
OHSU Knight Cancer Institute 27,500
Not applicableUnknownNCT03109522
What this trial is testing

Axillary Reverse Mapping (ARM) Technique

Who this might be right for
Invasive Breast CancerDuctal Carcinoma in Situ of the Breast
McMaster University 130
Testing effectiveness (Phase 2)Study completedNCT00054301
What this trial is testing

Radiation Therapy After Lumpectomy in Treating Women With Ductal Carcinoma in Situ or Invasive Breast Cancer

Who this might be right for
Breast Cancer
Case Comprehensive Cancer Center 2
Not applicableStudy completedNCT01841749
What this trial is testing

Management of Ductal Carcinoma in Situ or Pure Micro-invasive Extended Breast

Who this might be right for
Intraductal Carcinoma and Lobular Carcinoma in Situ
Institut Bergonié 228
Next Page